Japan Lung Cancer Market Set To Skyrocket To US$ 9,376.83 Million By 2032 | Astute Analytica
(MENAFN- GlobeNewsWire - Nasdaq) Japan lung cancer market is dynamically evolving through advancements in precision medicine, genetic profiling, and immunotherapies. government initiatives and substantial R&D investments are driving early detection and …